February 16, 2023
Feature Articles
32
1/2
Considerations to help tailor new tools as part of a custom clinical trial strategy.
February 16, 2023
Feature Articles
32
1/2
Simultaneous and niche skills sought amid evolution in clinical data management.
February 16, 2023
Feature Articles
32
1/2
Assessing industry’s use and integration of clinical data science across business.
February 15, 2023
Data Collection
32
1/2
Despite high potential of DHTs, regulatory picture remains unclear.
February 15, 2023
View from Washington
32
1/2
Probe targets agency’s role in advising on drug testing and submissions.
February 15, 2023
From the Editor
32
1/2
Highlights from the annual SCOPE conference held in Orlando, FL.
February 15, 2023
Issue PDF
32
1/2
Click the title above for a link to open the Applied Clinical Trials January/February 2023 issue in an interactive PDF format.
February 03, 2023
A Closing Thought
32
1/2
DCTs and RWD among topics for industry to focus on moving into 2023.
January 24, 2023
View from Brussels
32
1/2
The issues engulfing compliance with the Clinical Trials Regulation signal that even the best intentions with these types of laws may not be enough to avert unintended consequences.
December 30, 2022
Feature Articles
32
1/2
How evidence generated by the latest IgniteData ‘real-setting’ pilot study supports the case for clinical trial transformation.
December 27, 2022
Q&A
32
1/2
Sam Whitaker, co-founder and co-CEO of Mural Health discusses his time in the industry and patient needs in the current clinical trials market.